Search Results 171-180 of 2470 for 2024embarking
placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...
Academic degrees are granted by the Mayo Clinic Board of Trustees on the recommendation of the deans and the faculty of Mayo Clinic College of Medicine and ...
This week's episode of Tomorrow's Cure comes to you from the PlatforMed Conference, held in June 2025 in Minneapolis. The event brought together more than ...
The purpose of this study is to determine the correlation of the MCTS - CT with standard coagulation tests and coagulation factor levels. Participation ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to determine if prostate cancer patients treated with proton therapy as compared to IMRT experience improved QOL (validated EPIC ...
There has been ongoing debate about the relationship between cancer recurrence and anesthetic management. Therefore, the investigators will test the hypothesis ...
The primary purpose of this trial is to determine the safety of XC001 (AdVEGFXC1) in patients who suffer from angina caused by coronary artery disease and have ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.